A-kinase anchor protein 12 (AKAP12) (AKAP12)

A-kinase anchor protein 12 (AKAP12), also known as Gravin or SSeCKS (Src-suppressed C kinase substrate), is a large scaffolding protein that plays a critical role in organizing signaling complexes by anchoring protein kinase A (PKA), protein kinase C (PKC), and calmodulin to specific subcellular locations (UniProt Q02952). By spatially and temporally regulating these kinases, AKAP12 controls essential cellular processes such as cell cycle progression, actin cytoskeleton remodeling, and signal transduction pathways like the mitogen-activated protein kinase (MAPK) cascade (Gelman, 2010). In clinical contexts, AKAP12 is widely recognized as a tumor suppressor, and its expression is frequently silenced in various malignancies, including prostate, breast, and lung cancers, often through epigenetic mechanisms like promoter hypermethylation (Akakura & Gelman, 2012). Beyond oncology, AKAP12 is involved in maintaining the integrity of the blood-brain barrier and regulating inflammatory responses in the vascular system (NCBI Gene 9590). While there are currently no approved drugs that directly bind the AKAP12 protein, therapeutic strategies focus on restoring its expression using DNA methyltransferase inhibitors like Decitabine or targeting its mRNA transcript for modulation in fibrotic and cardiovascular diseases. The mRNA of AKAP12 serves as a critical point of regulation, and its levels are often used as a biomarker for disease progression and therapeutic response in cancer patients.

Other names

GravinSSeCKSSrc-suppressed C kinase substrateAKAP250AKAP12 mRNA

Restoration of AKAP12 expression through DNA demethylation of its promoter region; spatial regulation of PKA and PKC signaling